Laura Maintz

Bonn, NW, Germany

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications

Safety and efficacy of nemolizumab for atopic dermatitis up to 2 years in open-label extension study.

Safety and efficacy of nemolizumab for atopic dermatitis up to 2 years in open-label extension study.

Journal: Journal of the European Academy of Dermatology and Venereology : JEADV
Published: June 30, 2025

From Disease Control to Disease Modification: The Atopic Dermatitis Disease Activity Index.

From Disease Control to Disease Modification: The Atopic Dermatitis Disease Activity Index.

Journal: Allergy
Published: June 24, 2025

Deciphering the Connection Between Atopic Dermatitis and Cardiovascular Diseases: Analysis of Clinical Associations and Cardiometabolic Proteins.

Deciphering the Connection Between Atopic Dermatitis and Cardiovascular Diseases: Analysis of Clinical Associations and Cardiometabolic Proteins.

Journal: Allergy
Published: December 16, 2024

Navigating the evolving landscape of atopic dermatitis: Challenges and future opportunities: The 4th Davos declaration.

Navigating the evolving landscape of atopic dermatitis: Challenges and future opportunities: The 4th Davos declaration.

Journal: Allergy
Published: February 09, 2024

Development of a clinical algorithm to predict phenotypic switches between atopic dermatitis and psoriasis (the "Flip-Flop" phenomenon).

Development of a clinical algorithm to predict phenotypic switches between atopic dermatitis and psoriasis (the "Flip-Flop" phenomenon).

Journal: Allergy
Published: April 19, 2023

Founder Variants in KRT5 and POGLUT1 Are Implicated in Dowling-Degos Disease.

Founder Variants in KRT5 and POGLUT1 Are Implicated in Dowling-Degos Disease.

Journal: The Journal of investigative dermatology
Published: April 13, 2023

Treatment of atopic dermatitis: Recently approved drugs and advanced clinical development programs.

Treatment of atopic dermatitis: Recently approved drugs and advanced clinical development programs.

Journal: Allergy
Published: February 05, 2023

Immunoglobulin E autoantibodies in atopic dermatitis associate with Type-2 comorbidities and the atopic march.

Immunoglobulin E autoantibodies in atopic dermatitis associate with Type-2 comorbidities and the atopic march.

Journal: Allergy
Published: November 19, 2022

Atopic dermatitis: Correlation of distinct risk factors with age of onset in adulthood compared to childhood.

Atopic dermatitis: Correlation of distinct risk factors with age of onset in adulthood compared to childhood.

Journal: Allergy
Published: October 10, 2022

IL-13, periostin and dipeptidyl-peptidase-4 reveal endotype-phenotype associations in atopic dermatitis.

IL-13, periostin and dipeptidyl-peptidase-4 reveal endotype-phenotype associations in atopic dermatitis.

Journal: Allergy
Published: August 09, 2022

From Skin Barrier Dysfunction to Systemic Impact of Atopic Dermatitis: Implications for a Precision Approach in Dermocosmetics and Medicine.

From Skin Barrier Dysfunction to Systemic Impact of Atopic Dermatitis: Implications for a Precision Approach in Dermocosmetics and Medicine.

Journal: Journal of personalized medicine
Published: April 15, 2022

Machine Learning-Based Deep Phenotyping of Atopic Dermatitis: Severity-Associated Factors in Adolescent and Adult Patients.

Machine Learning-Based Deep Phenotyping of Atopic Dermatitis: Severity-Associated Factors in Adolescent and Adult Patients.

Journal: JAMA dermatology
Published: November 10, 2021
Showing 1-12 of 23

Last Updated: 09/26/2026